Literature DB >> 25040933

Dorsal muscle group area and surgical outcomes in liver transplantation.

Christopher S Lee1, David C Cron, Michael N Terjimanian, Leah D Canvasser, Alyssa A Mazurek, Ellen Vonfoerster, Lindsay M Tishberg, Patrick W Underwood, Eric T Chang, Stewart C Wang, Christopher J Sonnenday, Michael J Englesbe.   

Abstract

INTRODUCTION: Better measures of liver transplant risk stratification are needed. Our previous work noted a strong relationship between psoas muscle area and survival following liver transplantation. The dorsal muscle group is easier to measure, but it is unclear if they are also correlated with surgical outcomes.
METHODS: Our study population included liver transplant recipients with a preoperative CT scan. Cross-sectional areas of the dorsal muscle group at the T12 vertebral level were measured. The primary outcomes for this study were one- and five-yr mortality and one-yr complications. The relationship between dorsal muscle group area and post-transplantation outcome was assessed using univariate and multivariate techniques.
RESULTS: Dorsal muscle group area measurements were strongly associated with psoas area (r = 0.72; p < 0.001). Postoperative outcome was observed from 325 patients. Multivariate logistic regression revealed dorsal muscle group area to be a significant predictor of one-yr mortality (odds ratio [OR] = 0.53, p = 0.001), five-yr mortality (OR = 0.53, p < 0.001), and one-yr complications (OR = 0.67, p = 0.007).
CONCLUSION: Larger dorsal muscle group muscle size is associated with improved post-transplantation outcomes. The muscle is easier to measure and may represent a clinically relevant postoperative risk factor.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  dorsal muscle group; end-stage liver disease; liver transplant; morphometric measure; psoas muscle; risk stratification; sarcopenia; surgical outcome

Mesh:

Year:  2014        PMID: 25040933      PMCID: PMC4205192          DOI: 10.1111/ctr.12422

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  14 in total

1.  The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality.

Authors:  D E Schaubel; C S Sima; N P Goodrich; S Feng; R M Merion
Journal:  Am J Transplant       Date:  2008-01-07       Impact factor: 8.086

2.  Sarcopenia and mortality after liver transplantation.

Authors:  Michael J Englesbe; Shaun P Patel; Kevin He; Raymond J Lynch; Douglas E Schaubel; Calista Harbaugh; Sven A Holcombe; Stewart C Wang; Dorry L Segev; Christopher J Sonnenday
Journal:  J Am Coll Surg       Date:  2010-06-26       Impact factor: 6.113

3.  Quantifying the eyeball test: sarcopenia, analytic morphomics, and liver transplantation.

Authors:  Michael J Englesbe
Journal:  Liver Transpl       Date:  2012-10       Impact factor: 5.799

4.  Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value.

Authors:  Puneeta Tandon; Michael Ney; Ivana Irwin; Mang M Ma; Leah Gramlich; Vincent G Bain; Nina Esfandiari; Vickie Baracos; Aldo J Montano-Loza; Robert P Myers
Journal:  Liver Transpl       Date:  2012-10       Impact factor: 5.799

5.  Prospective measurements of intra-abdominal volume and pulmonary function after repair of massive ventral hernias with the components separation technique.

Authors:  Sonya P Agnew; William Small; Edward Wang; Lewis J Smith; Ivan Hadad; Gregory A Dumanian
Journal:  Ann Surg       Date:  2010-05       Impact factor: 12.969

6.  Frailty, core muscle size, and mortality in patients undergoing open abdominal aortic aneurysm repair.

Authors:  Jay Soong-Jin Lee; Kevin He; Calista M Harbaugh; Douglas E Schaubel; Christopher J Sonnenday; Stewart C Wang; Michael J Englesbe; Jonathan L Eliason
Journal:  J Vasc Surg       Date:  2011-01-07       Impact factor: 4.268

7.  Impact of sarcopenia on survival in patients undergoing living donor liver transplantation.

Authors:  T Kaido; K Ogawa; Y Fujimoto; Y Ogura; K Hata; T Ito; K Tomiyama; S Yagi; A Mori; S Uemoto
Journal:  Am J Transplant       Date:  2013-04-19       Impact factor: 8.086

Review 8.  Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives.

Authors:  Y Rolland; S Czerwinski; G Abellan Van Kan; J E Morley; M Cesari; G Onder; J Woo; R Baumgartner; F Pillard; Y Boirie; W M C Chumlea; B Vellas
Journal:  J Nutr Health Aging       Date:  2008 Aug-Sep       Impact factor: 4.075

9.  Effects of smoking on survival for patients with end-stage liver disease.

Authors:  Dennis S Lee; Amit K Mathur; William B Acker; Shaza N Al-Holou; Lauren K Ehrlichman; Sarah A Lewin; Christopher K B Nguyen; Sarah F Peterson; David N Ranney; Kristen Sell; James Kubus; Michael J Englesbe
Journal:  J Am Coll Surg       Date:  2009-04-24       Impact factor: 6.113

10.  Analytic morphomics, core muscle size, and surgical outcomes.

Authors:  Michael J Englesbe; Jay S Lee; Kevin He; Ludi Fan; Douglas E Schaubel; Kyle H Sheetz; Calista M Harbaugh; Sven A Holcombe; Darrel A Campbell; Christopher J Sonnenday; Stewart C Wang
Journal:  Ann Surg       Date:  2012-08       Impact factor: 12.969

View more
  19 in total

Review 1.  5th International ACC Symposium: Surgical Considerations in the Treatment of Adrenocortical Carcinoma: 5th International ACC Symposium Session: Who, When and What Combination?

Authors:  Barbra S Miller
Journal:  Horm Cancer       Date:  2016-01-04       Impact factor: 3.869

2.  CT of Patients With Hip Fracture: Muscle Size and Attenuation Help Predict Mortality.

Authors:  Robert D Boutin; Sara Bamrungchart; Cyrus P Bateni; Daniel P Beavers; Kristen M Beavers; John P Meehan; Leon Lenchik
Journal:  AJR Am J Roentgenol       Date:  2017-03-07       Impact factor: 3.959

3.  Morphomic Factors Associated With Complete Response to Neoadjuvant Therapy in Esophageal Carcinoma.

Authors:  Chien-Hung Chiu; Peng Zhang; Andrew C Chang; Brian A Derstine; Brian E Ross; Binu Enchakalody; Nidhi V Shah; Stewart C Wang; Yin-Kai Chao; Jules Lin
Journal:  Ann Thorac Surg       Date:  2019-09-21       Impact factor: 4.330

4.  Quantifying Sarcopenia Reference Values Using Lumbar and Thoracic Muscle Areas in a Healthy Population.

Authors:  B A Derstine; S A Holcombe; R L Goulson; B E Ross; N C Wang; J A Sullivan; G L Su; S C Wang
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

5.  Opportunistic muscle measurements on staging chest CT for extremity and truncal soft tissue sarcoma are associated with survival.

Authors:  Eileen N Phan; Steven W Thorpe; Felix S Wong; Augustine M Saiz; Sandra L Taylor; Robert J Canter; Leon Lenchik; R Lor Randall; Robert D Boutin
Journal:  J Surg Oncol       Date:  2020-07-01       Impact factor: 3.454

6.  Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients.

Authors:  Pratima Sharma; Neehar D Parikh; Jessica Yu; Pranab Barman; Brian A Derstine; Christopher J Sonnenday; Stewart C Wang; Grace L Su
Journal:  Liver Transpl       Date:  2016-06-29       Impact factor: 5.799

7.  Impact of body mass index on posttransplant outcomes reexamined.

Authors:  Khurram Bari; Pratima Sharma
Journal:  Liver Transpl       Date:  2015-10       Impact factor: 5.799

8.  Sarcopenia in Liver Transplantation.

Authors:  John Montgomery; Michael Englesbe
Journal:  Curr Transplant Rep       Date:  2019-01-21

9.  Longitudinal CT study of sarcopenia due to hepatic failure after living donor liver transplantation.

Authors:  Takahiro Onuma; Tamotsu Kamishima; Tsuyoshi Shimamura; Norio Kawamura; Kenichiro Yamashita; Kenneth Sutherland; Hiroshi Takeda
Journal:  Quant Imaging Med Surg       Date:  2018-02

10.  Higher Mortality in Pediatric Liver Transplant Candidates With Sarcopenia.

Authors:  Julia M Boster; Lorna P Browne; Zhaoxing Pan; Wenru Zhou; Peter F Ehrlich; Shikha S Sundaram
Journal:  Liver Transpl       Date:  2021-06       Impact factor: 6.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.